An Efficacy-Dependent Effect of Cardiac Overexpression of β2-Adrenoceptor on Ligand Affinity in Transgenic Mice

Abstract

In previous studies, it was shown that the overexpression of β2-adrenoceptor (β2AR) in the hearts of transgenic mice (Tg) leads to agonist-independent activation of adenylate cyclase and enhanced myocardial function. Here, we measured the physical coupling of β2AR and Gs by evaluating the coimmunoprecipitation of β2AR and Gs and the ligand binding properties of β2AR in the hearts of Tg mice to investigate the details of the interaction among ligand, receptor, and G protein. The following results were obtained: (i) coimmunoprecipitation of β2AR and Gs was increased in the absence of agonist in Tg mice compared with the control animals. This demonstrates directly the increased interaction between unliganded β2AR and Gs, which is consistent with increased background cAMP production and cardiac function in the hearts of Tg mice. (ii) Guanosine-5′-(β,γ-imido)triphosphate abolished the association of β2AR/Gs in the immunoprecipitate. (iii) The affinities for ligands that show agonist (isoproterenol, clenbuterol, and dobutamine), neutral antagonist (alprenolol and timolol), and negative antagonist (propranolol and ICI 118551) activities in this experimental system were increased, not changed and decreased, respectively, in Tg mice compared with the controls. (iv) This efficacy-dependent alteration in ligand affinities was still observed in the presence of a guanosine-5′-(β,γ-imido)triphosphate concentration that abolishes β2AR/Gscoupling. This suggests that the altered β2AR binding affinities in Tg mice are not due to the increased interaction between β2AR and Gs. These data cannot be explained by using ternary, quinternary, two-state extended ternary, or cubic ternary complex models. We therefore discuss the results using a “two-state polymerization model” that includes an isomerization step for the conversion of receptor between an inactive and an active form (denoted as R and R*, respectively) and a polymerization of the active state (R*n). The simplest form of this model (i.e., noncooperative dimerization of the receptor) is found to be consistent with the experimental data.

Footnotes

  • Send reprint requests to: Dr. H. Gürdal, AnkaraÜniversitesi Tip Fakültesi, Farmakoloji Ab.D., Sihhiye 06100, Ankara, Turkey. E-mail:gurdal{at}bilkent.edu.tr

  • This work is supported in part by Turkish Scientific and Technical Research Council Grants SBAG 1634 (H.G.) and SBAG AYD-98 (H.O.O. and H.G.); American Heart Association, Texas Affiliate, Grant 96R-458 (R.A.B.); Allegheny-Singer Research Institute; and American Heart Association, Southeastern Pennsylvania and Delaware Affiliates (M.D.J. and E.F.).

  • Abbreviations:
    GPCR
    G protein-coupled receptor
    β2AR
    β2-adrenoceptor
    ALP
    alprenolol
    Gpp(NH)p
    guanosine-5′-(β,γ-imido)triphosphate
    ICYP
    iodocyanopindolol
    ISO
    isoproterenol
    CLE
    clenbuterol
    DOB
    dobutamine
    TIM
    timolol
    PRO
    propranolol
    TCM
    ternary complex model
    Tg
    transgenic
    PBS
    phosphate-buffered saline
    • Received October 23, 1996.
    • Accepted May 5, 1997.
« Previous | Next Article »Table of Contents